CEO Geir Åge Løset and CBO Ole Henrik Brekke will attend the BIO International Convention June 8th – 12th. Book us for a digital meeting and we will present our unique NextCore Immunology platform. Learn how this technology can leverage the target and drug discovery in complex immunological diseases. https://www.bio.org/events/bio-digital
